Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: Systematic review

Journal of Vascular and Interventional Radiology

Volumn 24, Issue 8, 2013, Pages 1209-1217

  Richardson, Arthur J ^a,b   Laurence, Jerome M ^a,b   Lam, Vincent W T ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ABDOMINAL PAIN; ADVERSE DRUG REACTION; ANOREXIA; ARTICLE; ASTHENIA; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CHOLECYSTITIS; COLORECTAL LIVER METASTASIS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELUTING STENT; DRUG FATALITY; DRUG HALF LIFE; DRUG SAFETY; HEART INFARCTION; HUMAN; HYPERTENSION; INOPERABLE CANCER; INTERMETHOD COMPARISON; LIVER DYSFUNCTION; META ANALYSIS; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PAIN; POSTEMBOLIZATION SYNDROME; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; SURVIVAL TIME; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

5-FLUOROURACIL; 5-FLUOROURACIL/LEUCOVORIN/IRINOTECAN; 5-FLUOROURACIL/LEUCOVORIN/OXALIPLATIN; 5-FU; COLORECTAL LIVER METASTASIS; COMPLETE RESPONSE; CR; CRLM; DEB; DEBIRI; DRUG-ELUTING BEAD; DRUG-ELUTING BEADS WITH IRINOTECAN; FOLFIRI; FOLFOX; OS; OVERALL SURVIVAL; PARTIAL RESPONSE; PFS; PR; PROGRESSION-FREE SURVIVAL; QOL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RCT; SD; STANDARD DEVIATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CHEMOEMBOLIZATION, THERAPEUTIC; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DRUG CARRIERS; HUMANS; LIVER NEOPLASMS; QUALITY OF LIFE; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84880738191     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2013.05.055     Document Type: Article

References (35)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108
2. M. Donadon, D. Ribero, G. Morris-Stiff, E.K. Abdalla, and J.N. Vauthey New paradigm in the management of liver-only metastases from colorectal cancer Gastrointest Cancer Res 1 2007 20 27
3. S. Manfredi, C. Lepage, C. Hatem, O. Coatmeur, J. Faivre, and A.M. Bouvier Epidemiology and management of liver metastases from colorectal cancer Ann Surg 244 2006 254 259
4. P. Thirion, S. Michiels, and J.P. Pignon Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis J Clin Oncol 22 2004 3766 3775
5. R.M. Goldberg, D.J. Sargent, and R.F. Morton A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 2004 23 30
6. H. Hurwitz, L. Fehrenbacher, and W. Novotny Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342
7. A.F. Sobrero, J. Maurel, and L. Fehrenbacher EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer J Clin Oncol 26 2008 2311 2319
8. J. Bruix, and M. Sherman Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
9. K.A. Yao, M.S. Talamonti, and A. Nemcek Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors Surgery 130 2001 677 682
10. C. Aliberti, M. Tilli, G. Benea, and G. Fiorentini Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results Anticancer Res 26 2006:3793-2795
11. Z. Morise, A. Sugioka, R. Kato, J. Fujita, S. Hoshimoto, and T. Kato Transarterial chemoembolization with degradable starch microspheres, irinotecan, and mitomycin-C in patients with liver metastases J Gastrointest Surg 10 2006 249 258
12. G. Fiorentini, C. Aliberti, and G. Turrisi Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study In Vivo 21 2007 1085 1091
13. G. Fiorentini, C. Aliberti, and G. Benea TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: beneficial effect of palliative intra-arterial lidocaine and post-procedure supportive therapy on the control of side effects Hepatogastroenterology 55 2008 2077 2082
14. C. Aliberti, G. Fiorentini, and P.C. Muzzio Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead(R), drug-eluting bead loaded with irinotecan: results of a phase II clinical study Anticancer Res 31 2011 4581 4587
15. G. Fiorentini, C. Aliberti, and M. Tilli Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study Anticancer Res 32 2012 1387 1395
16. M. Bower, T. Metzger, and K. Robbins Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study HPB 12 2010 31 36
17. R.C. Martin, J. Joshi, and K. Robbins Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study Ann Surg Oncol 18 2011 192 198
18. R.C. Martin II, C.R. Scoggins, and D. Tomalty Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial J Gastrointest Surg 16 2012 1531 1538
19. T.J. Vogl, A. Jost, N.A. Nour-Eldin, M.G. Mack, S. Zangos, and N.N. Naguib Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced thermotherapy in patients with liver metastases of colorectal carcinoma Br J Cancer 106 2012 1274 1279
20. K. Eichler, S. Zangos, and M.G. Mack First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI) Int J Oncol 41 2012 1213 1220
21. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
22. M. Rees, P.P. Tekkis, F.K. Welsh, T. O'Rourke, and T.G. John Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients Ann Surg 247 2008 125 135
23. M.D. Smith, and J.L. McCall Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases Br J Surg 96 2009 1101 1113
24. S. Bhattacharjya, R. Aggarwal, and B.R. Davidson Intensive follow-up after liver resection for colorectal liver metastases: results of combined serial tumour marker estimations and computed tomography of the chest and abdomen - a prospective study Br J Cancer 95 2006 21 26
25. Y. Tang, R.R. Taylor, M.V. Gonzalez, A.L. Lewis, and P.W. Stratford Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases J Control Release 116 2006 e55 e56
26. I. Sakamoto, N. Aso, and K. Nagaoki Complications associated with transcatheter arterial embolization for hepatic tumors Radiographics 18 1998 605 619
27. N. Baize, B. Gerard, and H. Bleiberg Long-term survival of patients downstaged by oxaliplatin and 5-fluorouracil combination followed by rescue surgery for unresectable colorectal liver metastases Gastroenterol Clin Biol 30 2006 1349 1353
28. R. Adam, V. Delvart, and G. Pascal Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg 240 2004 644 657
29. V.W. Lam, C. Spiro, and J.M. Laurence A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases Ann Surg Oncol 19 2012 1292 1301
30. E. Seront, and M. Van den Eynde Liver-directed therapies: does it make sense in the current therapeutic strategy for patients with confined liver colorectal metastases? Clin Colorectal Cancer 11 2012 177 184
31. A. Kennedy, S. Nag, and R. Salem Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium Int J Radiat Oncol Biol Phys 68 2007 13 23
32. R. Salem, and K.G. Thurston Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations J Vasc Interv Radiol 17 2006 1251 1278
33. R.A. Sharma, G.A. Van Hazel, and B. Morgan Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy J Clin Oncol 25 2007 1099 1106
34. G.A. van Hazel, N. Pavlakis, and D. Goldstein Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy J Clin Oncol 27 2009 4089 4095
35. A. Hendlisz, M. Van den Eynde, and M. Peeters Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy J Clin Oncol 28 2010 3687 3694